Claypond Capital Names S Subramanyam to Lead Medical Tech Platform

Claypond Capital, the family investment arm of Manipal Group chairman Ranjan Pai has appointed Shravan Subramanyam, former Managing Director of Wipro-GE Healthcare, to lead its medical technology platform, the company said in a statement.

Subramaniam's career

Subramanyam is a physician from Madras Medical College with a master's degree in healthcare administration from Cornell University. He has 20 years of experience working with life sciences and medical device companies, including Roche and Novartis in various regions.

He has also been the president of NATHEALTH (Healthcare Federation of India) and co-chair of the Medical Technology committees for FICCI and CII.

Read also- Kammal Daas Joins Ecom Express As VP Of Last Mile Operations

Shravan Subramanyam, said, "The next decade holds a lot of promise for medical innovation and integration of various technologies, particularly digital solutions. I look forward to working closely with med-tech companies on behalf of Claypond, to scale up their presence in South Asia and overseas."

Manipal Group's chairman Ranjan Pai, said, "Healthcare delivery is changing profoundly in the post-Covid world, and medical technology has a big role to play in making healthcare accessible and affordable. Innovation will require long term capital and collaboration between industry and academia. We believe the platform approach will address the opportunity for India to participate in the growth of the med-tech sector across regions."

Subramanyam's appointment highlights Claypond Capital's focus on advancing medical technology in India and globally. His expertise is expected to play a key role in growing med-tech initiatives.

Advertisment

Funding News: Your Gateway to Every Funding Update.

Startup News: Stay updated with the latest startup news and trends. Your go-to source for startup ecosystem updates.

Startup Stories: Discover inspiring tales of startups overcoming challenges and achieving success.